Results for “”

Entry Author Date Location
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs 01/31/20 San Diego
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D 01/30/20 Boston
Vizgen Launches With $14M to Market New Subcellular Imaging Technique 01/30/20 Boston
Annovis Bio Gets $12M in IPO to Target Trio of Neurotoxic Proteins 01/29/20 New York
Spring Bank Pharma Ends Hepatitis B Work After Death in Clinical Trial 01/29/20 Boston
Agenda and Speakers Announced for Xcelerating Life Sciences San Diego 01/29/20 National
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus 01/29/20 Boston
Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets 01/28/20 San Diego
Third Time’s the Charm as Acceleron Drug Shows Early Promise in PAH 01/28/20 Boston
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Flagship Adds Fertility-Focused Ohana Biosciences to Biotech Family 01/27/20 Boston
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie 01/27/20 National
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Epizyme’s Soft Tissue Cancer Drug Granted Speedy FDA Approval 01/23/20 Boston
After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune 01/23/20 National
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs 01/22/20 Boston
Horizon Gets Early FDA OK for First Thyroid Eye Disease Treatment 01/22/20 National
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits 01/22/20 New York
CEOs of Women’s Health Companies Fight to Open Investment Floodgates 01/22/20 San Diego
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020 01/21/20 San Diego
Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights 01/21/20 Boston
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers 01/17/20 San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal 01/16/20 Boston
Page 2 of 1959 « previous page · next page »